Novel diagnosis and treatment agent with integrated functions of copper ion fluorescence detection and drug therapy and preparation method of novel diagnosis and treatment agent
A technology for fluorescence detection and treatment functions, applied in the directions of preparations, drug delivery, and drug combinations for in vivo experiments, it can solve the problems of prolonged treatment period, insensitive detection, long detection time, etc. High sensitivity and selective effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0042] This example provides NaYF 4 :Yb,Er@NaGdF 4 @mSiO 2 -P-DOX and its synthesis method, which include the following steps:
[0043] A method for preparing a novel nano-diagnostic and therapeutic agent for the integration of copper ion fluorescence detection and drug therapy functions, including the following steps:
[0044] (1) The up-conversion luminescent nanocrystal (NaYF) with a core-shell structure 4 :Yb,Er@NaYF 4 ) Dissolve in cyclohexane solution to obtain solution A;
[0045] Wherein, the up-conversion luminescent nanocrystal with core-shell structure (NaYF 4 :Yb,Er@NaYF 4 ) The preparation method of cyclohexane dispersion adopts solvothermal method, which specifically includes the following steps:
[0046] (1.1) 1M YCl 3 , 1M YbCl 3 , 0.1M ErCl 3 , 1M GdCl 3 , 2.5-3.75ml oleic acid, 6~8ml octadecene, 0.05~0.08g NaOH, 0.05~0.1g NH 4 F 4 , 20~25ml acetone, 15~20ml cyclohexane and 20~25ml methanol;
[0047] (1.2) Take 390 μL of YCl respectively 3 , 100μL YbCl 3 , 100μL ErCl 3 ...
Embodiment 2
[0088] This example provides NaYF 4 :Yb,Tm@NaGdF 4 @mSiO 2 -P-DOX and its synthesis method, which include the following steps:
[0089] A method for preparing a novel nano-diagnostic and therapeutic agent for the integration of copper ion fluorescence detection and drug therapy functions, including the following steps:
[0090] (1) The up-conversion luminescent nanocrystal (NaYF) with a core-shell structure 4 :Yb,Tm@NaGdF 4 ) Disperse in cyclohexane solution to obtain solution A;
[0091] Wherein, the up-conversion luminescent nanocrystal with core-shell structure (NaYF 4 :Yb,Tm@NaGdF 4 ) The preparation method of cyclohexane dispersion adopts solvothermal method, which specifically includes the following steps:
[0092] (1.1) 1M YCl 3 , 1M YbCl 3 , 0.1M TmCl 3 , 1M GdCl 3 , 2.5-3.75ml oleic acid, 6~8ml octadecene, 0.05~0.08g NaOH, 0.05~0.1g NH 4 F 4 , 20~25ml acetone, 15~20ml cyclohexane and 20~25ml methanol;
[0093] (1.2) Take 390 μL of YCl respectively 3 , 100μL YbCl 3 , 100μL TmCl ...
Embodiment 3
[0119] This example provides NaY / GdF 4 :Yb,Er@NaYF 4 @mSiO 2 -P-DOX and its synthesis method, which include the following steps:
[0120] A preparation method of a novel nano-diagnostic and therapeutic agent for the integration of copper ion fluorescence detection and drug therapy functions, including the following steps:
[0121] (1) Upconversion luminescent nanocrystals (NaY / GdF) with core-shell structure 4 :Yb,Er@NaYF 4 ) Disperse in cyclohexane solution to obtain solution A;
[0122] Wherein, the up-conversion luminescent nanocrystal (NaY / GdF 4 :Yb,Er@NaYF 4 ) The preparation method of cyclohexane dispersion adopts solvothermal method, which specifically includes the following steps:
[0123] (1.1) 1M YCl 3 , 1M YbCl 3 , 0.1M ErCl 3 , 1M GdCl 3 , 2.5-3.75ml oleic acid, 6~8ml octadecene, 0.05~0.08g NaOH, 0.05~0.1g NH 4 F 4 , 20~25ml acetone, 15~20ml cyclohexane and 20~25ml methanol;
[0124] (1.2) Take 275μL of YCl respectively 3 , 100μL YbCl 3 , 100μL ErCl 3 , 125μL GdCl 3 Remove wa...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


